nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Dyspepsia—Alendronate—osteoporosis	0.00232	0.00232	CcSEcCtD
Nalbuphine—Paraesthesia—Ibandronate—osteoporosis	0.0023	0.0023	CcSEcCtD
Nalbuphine—Pollakiuria—Estradiol—osteoporosis	0.00229	0.0023	CcSEcCtD
Nalbuphine—Dyspepsia—Raloxifene—osteoporosis	0.00228	0.00228	CcSEcCtD
Nalbuphine—Hypersensitivity—Etidronic acid—osteoporosis	0.00227	0.00228	CcSEcCtD
Nalbuphine—Loss of consciousness—Risedronate—osteoporosis	0.00227	0.00227	CcSEcCtD
Nalbuphine—Agitation—Pamidronate—osteoporosis	0.00226	0.00226	CcSEcCtD
Nalbuphine—Dyspepsia—Ibandronate—osteoporosis	0.00225	0.00226	CcSEcCtD
Nalbuphine—Anxiety—Ethinyl Estradiol—osteoporosis	0.00225	0.00225	CcSEcCtD
Nalbuphine—Erythema—Zoledronate—osteoporosis	0.00225	0.00225	CcSEcCtD
Nalbuphine—Hypertension—Risedronate—osteoporosis	0.00223	0.00223	CcSEcCtD
Nalbuphine—Somnolence—Calcitriol—osteoporosis	0.00223	0.00223	CcSEcCtD
Nalbuphine—Depression—Estradiol—osteoporosis	0.00221	0.00221	CcSEcCtD
Nalbuphine—Syncope—Pamidronate—osteoporosis	0.0022	0.00221	CcSEcCtD
Nalbuphine—Dysgeusia—Zoledronate—osteoporosis	0.0022	0.0022	CcSEcCtD
Nalbuphine—Anxiety—Risedronate—osteoporosis	0.00219	0.00219	CcSEcCtD
Nalbuphine—Pruritus—Etidronic acid—osteoporosis	0.00218	0.00218	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Estropipate—osteoporosis	0.00218	0.00218	CcSEcCtD
Nalbuphine—Feeling abnormal—Alendronate—osteoporosis	0.00217	0.00217	CcSEcCtD
Nalbuphine—Oedema—Ethinyl Estradiol—osteoporosis	0.00216	0.00217	CcSEcCtD
Nalbuphine—Erythema—Conjugated Estrogens—osteoporosis	0.00216	0.00216	CcSEcCtD
Nalbuphine—Loss of consciousness—Pamidronate—osteoporosis	0.00216	0.00216	CcSEcCtD
Nalbuphine—Muscle spasms—Zoledronate—osteoporosis	0.00216	0.00216	CcSEcCtD
Nalbuphine—Dry mouth—Risedronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Alendronate—osteoporosis	0.00215	0.00215	CcSEcCtD
Nalbuphine—Convulsion—Pamidronate—osteoporosis	0.00213	0.00213	CcSEcCtD
Nalbuphine—Hypertension—Pamidronate—osteoporosis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Tension—Conjugated Estrogens—osteoporosis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Urticaria—Estropipate—osteoporosis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Vision blurred—Zoledronate—osteoporosis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00212	0.00212	CcSEcCtD
Nalbuphine—Body temperature increased—Estropipate—osteoporosis	0.00211	0.00211	CcSEcCtD
Nalbuphine—Abdominal pain—Estropipate—osteoporosis	0.00211	0.00211	CcSEcCtD
Nalbuphine—Feeling abnormal—Ibandronate—osteoporosis	0.00211	0.00211	CcSEcCtD
Nalbuphine—Tremor—Zoledronate—osteoporosis	0.0021	0.0021	CcSEcCtD
Nalbuphine—Nervousness—Conjugated Estrogens—osteoporosis	0.0021	0.0021	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Nalbuphine—Urticaria—Alendronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Nalbuphine—Anxiety—Pamidronate—osteoporosis	0.00209	0.00209	CcSEcCtD
Nalbuphine—Abdominal pain—Alendronate—osteoporosis	0.00208	0.00208	CcSEcCtD
Nalbuphine—Body temperature increased—Alendronate—osteoporosis	0.00208	0.00208	CcSEcCtD
Nalbuphine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00208	0.00208	CcSEcCtD
Nalbuphine—Shock—Risedronate—osteoporosis	0.00208	0.00208	CcSEcCtD
Nalbuphine—Agitation—Zoledronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00205	0.00205	CcSEcCtD
Nalbuphine—Abdominal pain—Raloxifene—osteoporosis	0.00205	0.00205	CcSEcCtD
Nalbuphine—Body temperature increased—Raloxifene—osteoporosis	0.00205	0.00205	CcSEcCtD
Nalbuphine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00204	0.00204	CcSEcCtD
Nalbuphine—Urticaria—Ibandronate—osteoporosis	0.00203	0.00204	CcSEcCtD
Nalbuphine—Abdominal pain—Ibandronate—osteoporosis	0.00202	0.00203	CcSEcCtD
Nalbuphine—Body temperature increased—Ibandronate—osteoporosis	0.00202	0.00203	CcSEcCtD
Nalbuphine—Confusional state—Pamidronate—osteoporosis	0.00202	0.00202	CcSEcCtD
Nalbuphine—Vertigo—Zoledronate—osteoporosis	0.00202	0.00202	CcSEcCtD
Nalbuphine—Syncope—Zoledronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Nalbuphine—Oedema—Pamidronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Nalbuphine—Urticaria—Calcitriol—osteoporosis	0.00199	0.00199	CcSEcCtD
Nalbuphine—Body temperature increased—Calcitriol—osteoporosis	0.00198	0.00198	CcSEcCtD
Nalbuphine—Abdominal pain—Calcitriol—osteoporosis	0.00198	0.00198	CcSEcCtD
Nalbuphine—Hypoaesthesia—Estradiol—osteoporosis	0.00198	0.00198	CcSEcCtD
Nalbuphine—Shock—Pamidronate—osteoporosis	0.00197	0.00197	CcSEcCtD
Nalbuphine—Loss of consciousness—Zoledronate—osteoporosis	0.00197	0.00197	CcSEcCtD
Nalbuphine—Hypersensitivity—Estropipate—osteoporosis	0.00197	0.00197	CcSEcCtD
Nalbuphine—Vomiting—Etidronic acid—osteoporosis	0.00196	0.00196	CcSEcCtD
Nalbuphine—Tachycardia—Pamidronate—osteoporosis	0.00196	0.00196	CcSEcCtD
Nalbuphine—Rash—Etidronic acid—osteoporosis	0.00195	0.00195	CcSEcCtD
Nalbuphine—Convulsion—Zoledronate—osteoporosis	0.00195	0.00195	CcSEcCtD
Nalbuphine—Dermatitis—Etidronic acid—osteoporosis	0.00194	0.00195	CcSEcCtD
Nalbuphine—Vertigo—Conjugated Estrogens—osteoporosis	0.00194	0.00194	CcSEcCtD
Nalbuphine—Hyperhidrosis—Pamidronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Nalbuphine—Syncope—Conjugated Estrogens—osteoporosis	0.00194	0.00194	CcSEcCtD
Nalbuphine—Hypertension—Zoledronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Nalbuphine—Hypersensitivity—Alendronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Nalbuphine—Headache—Etidronic acid—osteoporosis	0.00193	0.00193	CcSEcCtD
Nalbuphine—Asthenia—Estropipate—osteoporosis	0.00192	0.00192	CcSEcCtD
Nalbuphine—Anxiety—Zoledronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Nalbuphine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.0019	0.0019	CcSEcCtD
Nalbuphine—Paraesthesia—Risedronate—osteoporosis	0.0019	0.0019	CcSEcCtD
Nalbuphine—Pruritus—Estropipate—osteoporosis	0.00189	0.00189	CcSEcCtD
Nalbuphine—Asthenia—Alendronate—osteoporosis	0.00189	0.00189	CcSEcCtD
Nalbuphine—Hypersensitivity—Ibandronate—osteoporosis	0.00189	0.00189	CcSEcCtD
Nalbuphine—Dyspnoea—Risedronate—osteoporosis	0.00188	0.00188	CcSEcCtD
Nalbuphine—Hypotension—Pamidronate—osteoporosis	0.00187	0.00188	CcSEcCtD
Nalbuphine—Convulsion—Conjugated Estrogens—osteoporosis	0.00187	0.00187	CcSEcCtD
Nalbuphine—Dry mouth—Zoledronate—osteoporosis	0.00187	0.00187	CcSEcCtD
Nalbuphine—Pruritus—Alendronate—osteoporosis	0.00186	0.00186	CcSEcCtD
Nalbuphine—Dyspepsia—Risedronate—osteoporosis	0.00186	0.00186	CcSEcCtD
Nalbuphine—Confusional state—Zoledronate—osteoporosis	0.00185	0.00185	CcSEcCtD
Nalbuphine—Hypersensitivity—Calcitriol—osteoporosis	0.00185	0.00185	CcSEcCtD
Nalbuphine—Flushing—Estradiol—osteoporosis	0.00184	0.00185	CcSEcCtD
Nalbuphine—Asthenia—Ibandronate—osteoporosis	0.00184	0.00184	CcSEcCtD
Nalbuphine—Anxiety—Conjugated Estrogens—osteoporosis	0.00183	0.00184	CcSEcCtD
Nalbuphine—Nausea—Etidronic acid—osteoporosis	0.00183	0.00183	CcSEcCtD
Nalbuphine—Oedema—Zoledronate—osteoporosis	0.00183	0.00183	CcSEcCtD
Nalbuphine—Pruritus—Ibandronate—osteoporosis	0.00181	0.00181	CcSEcCtD
Nalbuphine—Shock—Zoledronate—osteoporosis	0.0018	0.0018	CcSEcCtD
Nalbuphine—Paraesthesia—Pamidronate—osteoporosis	0.0018	0.0018	CcSEcCtD
Nalbuphine—Asthenia—Calcitriol—osteoporosis	0.0018	0.0018	CcSEcCtD
Nalbuphine—Dyspnoea—Pamidronate—osteoporosis	0.00179	0.00179	CcSEcCtD
Nalbuphine—Tachycardia—Zoledronate—osteoporosis	0.00179	0.00179	CcSEcCtD
Nalbuphine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00178	0.00178	CcSEcCtD
Nalbuphine—Somnolence—Pamidronate—osteoporosis	0.00178	0.00178	CcSEcCtD
Nalbuphine—Pruritus—Calcitriol—osteoporosis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Hyperhidrosis—Zoledronate—osteoporosis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Dyspepsia—Pamidronate—osteoporosis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Dizziness—Estropipate—osteoporosis	0.00177	0.00177	CcSEcCtD
Nalbuphine—Oedema—Conjugated Estrogens—osteoporosis	0.00176	0.00177	CcSEcCtD
Nalbuphine—Dizziness—Alendronate—osteoporosis	0.00174	0.00174	CcSEcCtD
Nalbuphine—Shock—Conjugated Estrogens—osteoporosis	0.00174	0.00174	CcSEcCtD
Nalbuphine—Erythema—Estradiol—osteoporosis	0.00173	0.00173	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Risedronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Nalbuphine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00172	0.00172	CcSEcCtD
Nalbuphine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00172	0.00172	CcSEcCtD
Nalbuphine—Hypotension—Zoledronate—osteoporosis	0.00171	0.00171	CcSEcCtD
Nalbuphine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00171	0.00171	CcSEcCtD
Nalbuphine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00171	0.00171	CcSEcCtD
Nalbuphine—Dizziness—Raloxifene—osteoporosis	0.00171	0.00171	CcSEcCtD
Nalbuphine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00171	0.00171	CcSEcCtD
Nalbuphine—Tension—Estradiol—osteoporosis	0.0017	0.0017	CcSEcCtD
Nalbuphine—Vomiting—Estropipate—osteoporosis	0.0017	0.0017	CcSEcCtD
Nalbuphine—Dysgeusia—Estradiol—osteoporosis	0.00169	0.0017	CcSEcCtD
Nalbuphine—Dizziness—Ibandronate—osteoporosis	0.00169	0.00169	CcSEcCtD
Nalbuphine—Rash—Estropipate—osteoporosis	0.00168	0.00168	CcSEcCtD
Nalbuphine—Dermatitis—Estropipate—osteoporosis	0.00168	0.00168	CcSEcCtD
Nalbuphine—Nervousness—Estradiol—osteoporosis	0.00168	0.00168	CcSEcCtD
Nalbuphine—Urticaria—Risedronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Nalbuphine—Headache—Estropipate—osteoporosis	0.00167	0.00167	CcSEcCtD
Nalbuphine—Vomiting—Alendronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Nalbuphine—Abdominal pain—Risedronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Nalbuphine—Body temperature increased—Risedronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Nalbuphine—Muscle spasms—Estradiol—osteoporosis	0.00166	0.00166	CcSEcCtD
Nalbuphine—Rash—Alendronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Nalbuphine—Dermatitis—Alendronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Nalbuphine—Feeling abnormal—Pamidronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Nalbuphine—Hypotension—Conjugated Estrogens—osteoporosis	0.00165	0.00165	CcSEcCtD
Nalbuphine—Headache—Alendronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Nalbuphine—Paraesthesia—Zoledronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Nalbuphine—Vomiting—Raloxifene—osteoporosis	0.00164	0.00165	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00164	0.00164	CcSEcCtD
Nalbuphine—Dyspnoea—Zoledronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Nalbuphine—Rash—Raloxifene—osteoporosis	0.00163	0.00163	CcSEcCtD
Nalbuphine—Dermatitis—Raloxifene—osteoporosis	0.00163	0.00163	CcSEcCtD
Nalbuphine—Somnolence—Zoledronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Nalbuphine—Vomiting—Ibandronate—osteoporosis	0.00163	0.00163	CcSEcCtD
Nalbuphine—Tremor—Estradiol—osteoporosis	0.00162	0.00162	CcSEcCtD
Nalbuphine—Headache—Raloxifene—osteoporosis	0.00162	0.00162	CcSEcCtD
Nalbuphine—Rash—Ibandronate—osteoporosis	0.00161	0.00162	CcSEcCtD
Nalbuphine—Dermatitis—Ibandronate—osteoporosis	0.00161	0.00161	CcSEcCtD
Nalbuphine—Dyspepsia—Zoledronate—osteoporosis	0.00161	0.00161	CcSEcCtD
Nalbuphine—Headache—Ibandronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Nalbuphine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00159	0.0016	CcSEcCtD
Nalbuphine—Vomiting—Calcitriol—osteoporosis	0.00159	0.00159	CcSEcCtD
Nalbuphine—Agitation—Estradiol—osteoporosis	0.00159	0.00159	CcSEcCtD
Nalbuphine—Nausea—Estropipate—osteoporosis	0.00159	0.00159	CcSEcCtD
Nalbuphine—Abdominal pain—Pamidronate—osteoporosis	0.00159	0.00159	CcSEcCtD
Nalbuphine—Body temperature increased—Pamidronate—osteoporosis	0.00159	0.00159	CcSEcCtD
Nalbuphine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00158	0.00159	CcSEcCtD
Nalbuphine—Rash—Calcitriol—osteoporosis	0.00158	0.00158	CcSEcCtD
Nalbuphine—Dermatitis—Calcitriol—osteoporosis	0.00158	0.00158	CcSEcCtD
Nalbuphine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00157	0.00157	CcSEcCtD
Nalbuphine—Headache—Calcitriol—osteoporosis	0.00157	0.00157	CcSEcCtD
Nalbuphine—Somnolence—Conjugated Estrogens—osteoporosis	0.00157	0.00157	CcSEcCtD
Nalbuphine—Nausea—Alendronate—osteoporosis	0.00156	0.00156	CcSEcCtD
Nalbuphine—Hypersensitivity—Risedronate—osteoporosis	0.00155	0.00156	CcSEcCtD
Nalbuphine—Vertigo—Estradiol—osteoporosis	0.00155	0.00156	CcSEcCtD
Nalbuphine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00155	0.00155	CcSEcCtD
Nalbuphine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00155	0.00155	CcSEcCtD
Nalbuphine—Syncope—Estradiol—osteoporosis	0.00155	0.00155	CcSEcCtD
Nalbuphine—Nausea—Raloxifene—osteoporosis	0.00154	0.00154	CcSEcCtD
Nalbuphine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00153	0.00153	CcSEcCtD
Nalbuphine—Nausea—Ibandronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Nalbuphine—Loss of consciousness—Estradiol—osteoporosis	0.00152	0.00152	CcSEcCtD
Nalbuphine—Asthenia—Risedronate—osteoporosis	0.00151	0.00151	CcSEcCtD
Nalbuphine—Feeling abnormal—Zoledronate—osteoporosis	0.00151	0.00151	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Zoledronate—osteoporosis	0.0015	0.0015	CcSEcCtD
Nalbuphine—Hypertension—Estradiol—osteoporosis	0.00149	0.00149	CcSEcCtD
Nalbuphine—Pruritus—Risedronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Nalbuphine—Nausea—Calcitriol—osteoporosis	0.00149	0.00149	CcSEcCtD
Nalbuphine—Hypersensitivity—Pamidronate—osteoporosis	0.00148	0.00148	CcSEcCtD
Nalbuphine—Anxiety—Estradiol—osteoporosis	0.00147	0.00147	CcSEcCtD
Nalbuphine—Urticaria—Zoledronate—osteoporosis	0.00146	0.00146	CcSEcCtD
Nalbuphine—Abdominal pain—Zoledronate—osteoporosis	0.00145	0.00145	CcSEcCtD
Nalbuphine—Body temperature increased—Zoledronate—osteoporosis	0.00145	0.00145	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00144	0.00144	CcSEcCtD
Nalbuphine—Dry mouth—Estradiol—osteoporosis	0.00144	0.00144	CcSEcCtD
Nalbuphine—Asthenia—Pamidronate—osteoporosis	0.00144	0.00144	CcSEcCtD
Nalbuphine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00143	0.00143	CcSEcCtD
Nalbuphine—Confusional state—Estradiol—osteoporosis	0.00142	0.00142	CcSEcCtD
Nalbuphine—Pruritus—Pamidronate—osteoporosis	0.00142	0.00142	CcSEcCtD
Nalbuphine—Oedema—Estradiol—osteoporosis	0.00141	0.00141	CcSEcCtD
Nalbuphine—Urticaria—Conjugated Estrogens—osteoporosis	0.0014	0.0014	CcSEcCtD
Nalbuphine—Dizziness—Risedronate—osteoporosis	0.0014	0.0014	CcSEcCtD
Nalbuphine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00139	0.0014	CcSEcCtD
Nalbuphine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00139	0.0014	CcSEcCtD
Nalbuphine—Shock—Estradiol—osteoporosis	0.00139	0.00139	CcSEcCtD
Nalbuphine—Tachycardia—Estradiol—osteoporosis	0.00138	0.00138	CcSEcCtD
Nalbuphine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00138	0.00138	CcSEcCtD
Nalbuphine—Hyperhidrosis—Estradiol—osteoporosis	0.00137	0.00137	CcSEcCtD
Nalbuphine—Rash—Ethinyl Estradiol—osteoporosis	0.00136	0.00137	CcSEcCtD
Nalbuphine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00136	0.00136	CcSEcCtD
Nalbuphine—Headache—Ethinyl Estradiol—osteoporosis	0.00136	0.00136	CcSEcCtD
Nalbuphine—Hypersensitivity—Zoledronate—osteoporosis	0.00135	0.00135	CcSEcCtD
Nalbuphine—Vomiting—Risedronate—osteoporosis	0.00134	0.00134	CcSEcCtD
Nalbuphine—Rash—Risedronate—osteoporosis	0.00133	0.00133	CcSEcCtD
Nalbuphine—Dermatitis—Risedronate—osteoporosis	0.00133	0.00133	CcSEcCtD
Nalbuphine—Dizziness—Pamidronate—osteoporosis	0.00133	0.00133	CcSEcCtD
Nalbuphine—Headache—Risedronate—osteoporosis	0.00132	0.00132	CcSEcCtD
Nalbuphine—Asthenia—Zoledronate—osteoporosis	0.00131	0.00132	CcSEcCtD
Nalbuphine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.0013	0.0013	CcSEcCtD
Nalbuphine—Pruritus—Zoledronate—osteoporosis	0.0013	0.0013	CcSEcCtD
Nalbuphine—Nausea—Ethinyl Estradiol—osteoporosis	0.00129	0.00129	CcSEcCtD
Nalbuphine—Vomiting—Pamidronate—osteoporosis	0.00128	0.00128	CcSEcCtD
Nalbuphine—Paraesthesia—Estradiol—osteoporosis	0.00127	0.00127	CcSEcCtD
Nalbuphine—Asthenia—Conjugated Estrogens—osteoporosis	0.00127	0.00127	CcSEcCtD
Nalbuphine—Rash—Pamidronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Nalbuphine—Dermatitis—Pamidronate—osteoporosis	0.00126	0.00126	CcSEcCtD
Nalbuphine—Dyspnoea—Estradiol—osteoporosis	0.00126	0.00126	CcSEcCtD
Nalbuphine—Headache—Pamidronate—osteoporosis	0.00126	0.00126	CcSEcCtD
Nalbuphine—Somnolence—Estradiol—osteoporosis	0.00126	0.00126	CcSEcCtD
Nalbuphine—Nausea—Risedronate—osteoporosis	0.00125	0.00125	CcSEcCtD
Nalbuphine—Pruritus—Conjugated Estrogens—osteoporosis	0.00125	0.00125	CcSEcCtD
Nalbuphine—Dyspepsia—Estradiol—osteoporosis	0.00124	0.00124	CcSEcCtD
Nalbuphine—Dizziness—Zoledronate—osteoporosis	0.00121	0.00121	CcSEcCtD
Nalbuphine—Nausea—Pamidronate—osteoporosis	0.00119	0.00119	CcSEcCtD
Nalbuphine—Dizziness—Conjugated Estrogens—osteoporosis	0.00117	0.00117	CcSEcCtD
Nalbuphine—Vomiting—Zoledronate—osteoporosis	0.00117	0.00117	CcSEcCtD
Nalbuphine—Feeling abnormal—Estradiol—osteoporosis	0.00116	0.00116	CcSEcCtD
Nalbuphine—Rash—Zoledronate—osteoporosis	0.00116	0.00116	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Estradiol—osteoporosis	0.00115	0.00116	CcSEcCtD
Nalbuphine—Dermatitis—Zoledronate—osteoporosis	0.00115	0.00115	CcSEcCtD
Nalbuphine—Headache—Zoledronate—osteoporosis	0.00115	0.00115	CcSEcCtD
Nalbuphine—Vomiting—Conjugated Estrogens—osteoporosis	0.00112	0.00112	CcSEcCtD
Nalbuphine—Urticaria—Estradiol—osteoporosis	0.00112	0.00112	CcSEcCtD
Nalbuphine—Body temperature increased—Estradiol—osteoporosis	0.00112	0.00112	CcSEcCtD
Nalbuphine—Abdominal pain—Estradiol—osteoporosis	0.00112	0.00112	CcSEcCtD
Nalbuphine—Rash—Conjugated Estrogens—osteoporosis	0.00111	0.00111	CcSEcCtD
Nalbuphine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00111	0.00111	CcSEcCtD
Nalbuphine—Headache—Conjugated Estrogens—osteoporosis	0.00111	0.00111	CcSEcCtD
Nalbuphine—Nausea—Zoledronate—osteoporosis	0.00109	0.00109	CcSEcCtD
Nalbuphine—Nausea—Conjugated Estrogens—osteoporosis	0.00105	0.00105	CcSEcCtD
Nalbuphine—Hypersensitivity—Estradiol—osteoporosis	0.00104	0.00104	CcSEcCtD
Nalbuphine—Asthenia—Estradiol—osteoporosis	0.00101	0.00101	CcSEcCtD
Nalbuphine—Pruritus—Estradiol—osteoporosis	0.000999	0.001	CcSEcCtD
Nalbuphine—Dizziness—Estradiol—osteoporosis	0.000934	0.000934	CcSEcCtD
Nalbuphine—Vomiting—Estradiol—osteoporosis	0.000898	0.000898	CcSEcCtD
Nalbuphine—Rash—Estradiol—osteoporosis	0.00089	0.000891	CcSEcCtD
Nalbuphine—Dermatitis—Estradiol—osteoporosis	0.00089	0.00089	CcSEcCtD
Nalbuphine—Headache—Estradiol—osteoporosis	0.000885	0.000885	CcSEcCtD
Nalbuphine—Nausea—Estradiol—osteoporosis	0.000839	0.000839	CcSEcCtD
Nalbuphine—Naloxone—ESR1—osteoporosis	0.000371	1	CrCbGaD
